PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Penn-Temple team discovers gatekeeper for maintaining health of cell energy source

2012-10-25
(Press-News.org) PHILADELPHIA - Most healthy cells rely on a complicated process to produce the fuel ATP. Knowing how ATP is produced by the cell's energy storehouse – the mitochondria -- is important for understanding a cell's normal state, as well as what happens when things go wrong, for example in cancer, cardiovascular disease, neurodegeneration, and many rare disorders of the mitochondria. Two years ago, Kevin Foskett, PhD, professor of Physiology at the Perelman School of Medicine, University of Pennsylvania, and colleagues discovered that fundamental control of ATP is an ongoing shuttle of calcium to the mitochondria from another cell compartment. They found that mitochondria rely on this transfer to make enough ATP to support normal cell metabolism. Now, Foskett's lab and the lab of co-corresponding author Muniswamy Madesh, PhD, at Temple University, have discovered an essential mechanism that regulates the flow of calcium into mitochondria, described in the October 26 issue of Cell. They demonstrated that the mitochondrial protein MICU1 is required to establish the proper level of calcium uptake under normal conditions. Maintaining the correct levels of calcium in the mitochondria plays an important role in cellular physiology: Calcium flux across the inner mitochondrial membrane regulates cell energy production and activation of cell-death pathways, for example. In MICU1's absence, Madesh and Foskett found that mitochondria become overloaded with calcium, generating excessive amounts of reactive oxygen molecules and eventually cell death. Decades in the Making Mitochondrial calcium has been studied for nearly five decades at Penn, starting with observations made by the late Britton Chance, the Eldridge Reeves Johnson Professor Emeritus of Biochemistry and Biophysics, in the 1960s, and physiologist Tony Scarpa, in the early 1970s. Calcium uptake is driven by a voltage across the inner mitochondrial membrane and mediated by a calcium-selective ion channel called the uniporter. While the proper level of calcium influx is required for mitochondria to produce enough ATP to support cellular processes, too much influx overloads mitochondria and is toxic. Because producing ATP generates a large negative voltage that attracts the positively charged calcium ion, mitochondria face an ongoing risk of becoming overloaded with calcium. Mitochondria somehow manage to keep the concentration of calcium in the mitochondrial matrix at beneficial levels. Remarkably, these levels are 100,000 to a million times lower than expected if calcium was simply in equilibrium with the cytoplasm. The molecular mechanisms for how this is accomplished have remained unclear. Foskett and Madesh discovered that MICU1 interacts with the uniporter calcium channel protein MCU and sets a brake for calcium uptake by the mitochondria. This regulation is essential to prevent an overload of calcium in the mitochondria and associated cellular stress. Past Studies Until recently, the molecular identity of the uniporter was unknown. MICU1 was identified as a protein found at the inner mitochondrial membrane and seemed to be required for uniporter calcium uptake. Subsequently, MCU was identified as the likely ion-conducting part of the uniporter. MICU1 and MCU interact biochemically and their expression patterns are tightly coupled across tissues and species. Nevertheless, the relationship between them was unknown. The Penn-Temple team found that loss of MICU1 leads to an accumulation of calcium in the mitochondria through MCU-mediated calcium uptake. Rather than being required for MCU-mediated mitochondrial calcium uptake, as previously thought, they found that MICU1 acts as the gatekeeper. MICU senses the concentration of calcium in the matrix of the mitochondria, establishing a set point that prevents calcium uptake under normal, resting concentrations of calcium. These findings reveal a previously unknown role for MICU1 in preventing an overload of calcium in the mitochondria. Foskett and Madesh speculate that the interaction between MICU1 and MCU may be an important site for regulating cellular bioenergetics and oxygen molecule signaling. They also suggest that disrupting the balance of the two molecules could lead to damage in neurons and cells of the heart, liver and other organs. "Mitochondrial calcium is important for metabolic and cardiovascular functions, and maintaining this homeostasis is crucial," comments Madesh. "Cells lacking the set point will lead to mitochondrial dysfunction and cell death." "Our findings suggest new therapeutics in a variety of pathophysiological conditions," notes first author Karthik Mallilankaraman from Temple. "If we could discover molecules or mechanisms to impinge on the biochemical or functional interactions of MICU1 and MCU, or to modify their activities, it may be possible that metabolic dysfunctions observed in many diseases could be manipulated with beneficial therapeutic outcomes," concludes Foskett. ### The research was supported by the National Institute of General Medical Science; the National Institute of Mental Health; and the National Heart, Lung, and Blood Institute (grants HL086699, HL086699-01A2S1, 1S10RR027327-01, GM56328, MH059937) as well as the American Heart Association and an NRSA Fellowship. Other co-authors are César Cárdenas, Marioly Müller, Russell Miller, Morris J. Birnbaum, Don-on Daniel Mak, all from Penn; Karthik Mallilankaraman, Patrick Doonan, Harish C. Chandramoorthy, Nicholas E. Hoffman, Rajesh Gandhirajan, and Brad Rothberg, all from Temple; and Jordi Molgó from the Institut de Neurobiologie Alfred Fessard, Laboratoire de Neurobiolgie et Développement, France.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital — the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.


ELSE PRESS RELEASES FROM THIS DATE:

Study reveals genetic causes of a male infertility disorder

2012-10-25
Severe spermatogenic failure (SSF) is a genetic condition that causes low sperm count and infertility. New insights into the genetic alterations that cause this disorder and their prevalence in populations of men around the world are provided by a study published by Cell Press in the American Journal of Human Genetics on October 25. The findings reveal which alterations are the greatest risk factors for the disease, and they could be immediately applicable in genetic counseling for assisted reproduction. "Medically relevant population genetics studies are well established ...

Anesthesia drugs really do put us to sleep

2012-10-25
When patients are put under anesthesia, they are often told they will be "put to sleep," and now it appears that in some ways that's exactly what the drugs do to the brain. New evidence in mice reported online on October 25 in Current Biology, a Cell Press publication, shows that the drugs don't just turn wakefulness "off," they also force important sleep circuits in the brain "on." "Despite more than 160 years of continuous use in humans, we still do not understand how anesthetic drugs work to produce the state of general anesthesia," said Max Kelz of the University ...

Stanford researchers develop efficient, protein-based method for creating iPS cells

2012-10-25
STANFORD, Calif. — Coaxing a humble skin cell to become a jack-of-all-trades pluripotent stem cell is feat so remarkable it was honored earlier this month with the Nobel Prize in Physiology or Medicine. Stem cell pioneer Shinya Yamanaka, MD, PhD, showed that using a virus to add just four genes to the skin cell allowed it to become pluripotent, or able to achieve many different developmental fates. But researchers and clinicians have been cautious about promoting potential therapeutic uses for these cells because the insertion of the genes could render the cells cancerous. Now ...

Genetic tradeoff: Harmful genes are widespread in yeast but hold hidden benefits

2012-10-25
ANN ARBOR— The genes responsible for inherited diseases are clearly bad for us, so why hasn't evolution, over time, weeded them out and eliminated them from the human genome altogether? Part of the reason seems to be that genes that can harm us at one stage of our lives are necessary and beneficial to us at other points in our development. The idea that the same gene can be both beneficial and harmful, depending on the situation, is called antagonistic pleiotropy. The theory has been around since the 1950s and has been used to explain aging, cancer and genetic diseases. But ...

Steroid injection linked to increased risk of bone fractures

Steroid injection linked to increased risk of bone fractures
2012-10-25
DETROIT – Patients treated with an epidural steroid injection for back pain relief are at increased risk of bone fractures in the spine, according to a Henry Ford Hospital study. Researchers say the risk of fracture increased 29 percent with each steroid injection, a finding they believe raises patient safety concerns. "For a patient population already at risk for bone fractures, steroid injections carry a greater risk that previously thought and actually pose a hazard to the bone," says Shlomo Mandel, M.D., a Henry Ford orthopedic physician and the study's lead author. Dr. ...

Male competition over females

Male competition over females
2012-10-25
When a female mates with several males, these will compete over the fertilization her eggs. This is an important evolutionary force that has led to the evolution of a diversity of male sexual organ morphologies. This is revealed in a study of seed beetles published today in the leading scientific journal Current Biology. In higher plants, the influential classification system developed by Carl von Linnaeus relied on the fact that the reproductive parts of plants are evolutionarily stable. This is in sharp contrast to the reproductive organs of animals with internal fertilization, ...

Temple-Penn team identifies gatekeeper protein, new details on cell's power source

2012-10-25
(Philadelphia, PA) – Researchers at Temple University's Center for Translational Medicine and the University of Pennsylvania have identified a protein that serves as a gatekeeper for controlling the rush of calcium into the cell's power source, the mitochondria. Without this calcium spigot under control, calcium levels can run amok, contributing to cardiovascular disease, diabetes and neurodegeneration. The findings, reported online October 25, 2012, in the journal Cell, add important new insights into the inner workings of the mitochondria and may eventually help scientists ...

An animal model of typhoid fever could lead to better vaccines

2012-10-25
The first mouse model of the common bacterial disease typhoid fever is reported in a study published by Cell Press October 25 in the journal Cell. Because the animals show human-like symptoms and respond positively to immunization, they could be used to develop more effective vaccines against the deadly pathogen. "Prior to our work, there was no small animal model for studying immune responses to the bacteria that cause typhoid fever," says study author Matthew Hayden of Columbia University. "We hope that the model we have developed will promote rapid progress in developing ...

Structure discovered for promising tuberculosis drug target

Structure discovered for promising tuberculosis drug target
2012-10-25
Researchers at Johns Hopkins have figured out the three-dimensional shape of the protein responsible for creating unique bonds within the cell wall of the bacteria that cause tuberculosis. The bonds make the bacteria resistant to currently available drug therapies, contributing to the alarming rise of these super-bacteria throughout the world. With the protein structure in hand, the scientists say, drug designers have a clear way forward for weakening the cell wall and killing these deadly bacteria. Their results are reported in a paper published online Oct. 25 in Structure. "We've ...

Scientists create first mouse model of typhoid fever

2012-10-25
New York, NY (October 25, 2012) — Columbia University Medical Center (CUMC) researchers have created the first true mouse model of typhoid infection. The development promises to advance the study of typhoid and the creation of new vaccines against the infection, which remains a major health threat in developing countries. The paper was published today in the online edition of the journal Cell. "Vaccines are the most practical solution for preventing typhoid in the Third World. Unfortunately, existing typhoid vaccines are only modestly effective, leaving millions of people ...

LAST 30 PRESS RELEASES:

How neighborhood perception affects housing rents: A novel analytical approach

Many adults report inaccurate beliefs about risks and benefits of home firearm access

Air pollution impacts an aging society

UC Davis researchers achieve total synthesis of ibogaine

Building better biomaterials for cancer treatments

Brain stimulation did not improve impaired motor skills after stroke

Some species of baleen whales avoid attracting killer whales by singing too low to be heard

Wasteful tests before surgery: Study shows how to reduce them safely

UCalgary researchers confirm best approach for stroke in medium-sized blood vessels

Nationwide, 34 local schools win NFL PLAY 60 grants to help students move more

New software developed at Wayne State University will help study chemical and biological systems

uOttawa study unveils new insights into how neural stem cells are activated in the adult human brain

Cystic fibrosis damages the immune system early on

Novel ‘living’ biomaterial aims to advance regenerative medicine

Warding off superbugs with a pinch of turmeric

Ophthalmic complications in patients on antidiabetic GLP-1 medications are concerning neuro-ophthalmologists

Physicians committee research policy director speaks today at hearing on taxpayer funded animal cruelty

New technology lights way for accelerating coral reef restoration

Electroencephalography may help guide treatments for language disorders

Multinational research project shows how life on Earth can be measured from space

Essential genome of malaria parasite Plasmodium knowlesi mapped

Ice streams move due to tiny ice quakes

Whale song has remarkable similarities to human speech in terms of efficiency

Uncovered: How mice override instinctive fear responses

A pathway that contributes to insulin resistance can be targeted, mouse study shows

Special Issue: The cryosphere

Scientists discover brain mechanism that helps overcome fear

Mantis shrimp clubs filter sound to mitigate damage

Large differences in water-seeking ability found in U.S. corn varieties

Whale song has structure similar to human language

[Press-News.org] Penn-Temple team discovers gatekeeper for maintaining health of cell energy source